Global prevalence, pathogens, and antimicrobial resistance patterns in hospital-acquired infections: a systematic review

Abstract Background Hospital-acquired infections (HAIs) represent a major global health concern, contributing substantially to increased morbidity, mortality, and healthcare costs. The rising prevalence of multidrug-resistant (MDR) organisms further complicates patient management worldwide. This systematic review aimed to synthesize global evidence on the prevalence of major HAIs and to characterize their associated microbial etiology and antimicrobial resistance patterns. Methods A systematic literature search was conducted in Medline (via PubMed), Embase, and Web of Science to identify studies published between January 2000 and December 2025. Studies reporting the prevalence of HAIs in human populations and providing sufficient demographic and microbiological data were included. Two independent reviewers screened titles, abstracts, and full texts, extracted relevant data, and assessed study quality using the Joanna Briggs Institute (JBI) checklist. Data on HAI prevalence, infection types, bacterial and fungal pathogens, and antimicrobial resistance patterns were synthesized. Results The overall observed prevalence across the included studies was 15.72%, but substantial heterogeneity (I² = 99%) precluded formal meta-analytic pooling, with the highest prevalence reported in Asia (43.04%) and Africa (34.07%). India exhibited the highest national prevalence (24.28%). The most frequently identified pathogens included Staphylococcus aureus , Escherichia coli ( E. coli ), Pseudomonas aeruginosa ( P. aeruginosa ), Klebsiella pneumoniae ( K. pneumoniae ), and Acinetobacter baumannii ( A. baumannii ), many of which demonstrated multidrug resistance. Among 300 S. aureus isolates assessed for vancomycin susceptibility, 35 (11.66%) were reported as VRSA; however, this proportion reflects only the isolates evaluated in the contributing studies and should not be interpreted as the global prevalence of VRSA. Respiratory tract infections, urinary tract infections, and surgical site infections were the most common HAI types, particularly among patients admitted to intensive care units (ICUs). Conclusion Hospital-acquired infections remain a significant global health challenge, with the greatest burden observed in Asia and Africa. The high prevalence of MDR pathogens, particularly S. aureus , E. coli , and P. aeruginosa , complicates clinical management, especially in ICU settings. Strengthening infection prevention and control measures, antimicrobial stewardship programs, and global surveillance systems is essential to reduce the burden of HAIs and improve patient outcomes. Due to insufficient and inconsistent reporting across the included studies, colistin resistance could not be comprehensively evaluated.

Authors

Institutions

Publication Details

Journal
BMC Infectious Diseases
Published
2026-10-13
DOI
https://doi.org/10.1186/s12879-026-14614-7
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Global prevalence, pathogens, and antimicrobial resistance patterns in hospital-acquired infections: a systematic review

Davood Yadegarynia, Saeid Gholami Gharab, Farzaneh Firoozeh, Bayat Sara et al.
BMC Infectious Diseases
Antibiotic Resistance in Bacteria
article

Global prevalence, pathogens, and antimicrobial resistance patterns in hospital-acquired infections: a systematic review

Davood Yadegarynia, Saeid Gholami Gharab, Farzaneh Firoozeh, Bayat Sara, Fatemeh Sameni, Masoud Dadashi, Kimia Kazemi, Mehdi Goudarzi
article en

Abstract

Abstract Background Hospital-acquired infections (HAIs) represent a major global health concern, contributing substantially to increased morbidity, mortality, and healthcare costs. The rising prevalence of multidrug-resistant (MDR) organisms further complicates patient management worldwide. This systematic review aimed to synthesize global evidence on the prevalence of major HAIs and to characterize their associated microbial etiology and antimicrobial resistance patterns. Methods A systematic literature search was conducted in Medline (via PubMed), Embase, and Web of Science to identify studies published between January 2000 and December 2025. Studies reporting the prevalence of HAIs in human populations and providing sufficient demographic and microbiological data were included. Two independent reviewers screened titles, abstracts, and full texts, extracted relevant data, and assessed study quality using the Joanna Briggs Institute (JBI) checklist. Data on HAI prevalence, infection types, bacterial and fungal pathogens, and antimicrobial resistance patterns were synthesized. Results The overall observed prevalence across the included studies was 15.72%, but substantial heterogeneity (I² = 99%) precluded formal meta-analytic pooling, with the highest prevalence reported in Asia (43.04%) and Africa (34.07%). India exhibited the highest national prevalence (24.28%). The most frequently identified pathogens included Staphylococcus aureus , Escherichia coli ( E. coli ), Pseudomonas aeruginosa ( P. aeruginosa ), Klebsiella pneumoniae ( K. pneumoniae ), and Acinetobacter baumannii ( A. baumannii ), many of which demonstrated multidrug resistance. Among 300 S. aureus isolates assessed for vancomycin susceptibility, 35 (11.66%) were reported as VRSA; however, this proportion reflects only the isolates evaluated in the contributing studies and should not be interpreted as the global prevalence of VRSA. Respiratory tract infections, urinary tract infections, and surgical site infections were the most common HAI types, particularly among patients admitted to intensive care units (ICUs). Conclusion Hospital-acquired infections remain a significant global health challenge, with the greatest burden observed in Asia and Africa. The high prevalence of MDR pathogens, particularly S. aureus , E. coli , and P. aeruginosa , complicates clinical management, especially in ICU settings. Strengthening infection prevention and control measures, antimicrobial stewardship programs, and global surveillance systems is essential to reduce the burden of HAIs and improve patient outcomes. Due to insufficient and inconsistent reporting across the included studies, colistin resistance could not be comprehensively evaluated.

BMC Infectious Diseases
Iran University of Medical Sciences (IR), Alborz University of Medical Sciences (IR), Shahid Beheshti University (IR), Shahid Beheshti University of Medical Sciences (IR)
Openalex Percentile: Top 23%
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.